leadf
logo-loader
viewMediPharm Labs

MediPharm announces deal with Pharma giant STADA that will transform company and cannabis sector

MediPharm Labs Corp (TSE: LABS-OTCQX: MEDIF) CEO Pat McCutcheon joined Steve Darling from Proactive to share details about an exclusive supply agreement European Consumer Healthcare and Generics company, STADA.

This deal will see MediPharm supply GMP certified medical cannabis products to STADA, as well as manufacturing, logistics, and regulatory support. McCutcheon discusses just how big this deal in for the company and also how it can also have a major ripple effect throughout the cannabis industry.

Quick facts: MediPharm Labs

Price: - -

TSX-V:LABS
Market: TSX-V
Market Cap: -
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of MediPharm Labs named herein, including the promotion by the Company of MediPharm Labs in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

MediPharma Labs - Proactive One2One Virtual Event

MediPharm Labs Corp's (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) CEO Pat McCutcheon presents to investors at the Proactive One2One Virtual Conference. MediPharm Labs specializes in the production of purified, pharmaceutical quality cannabis oil and concentrates and advanced derivative products...

on 10/8/20

2 min read